NEW YORK, NY / ACCESS Newswire / December 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation into Surgery Partners, Inc. ("Surgery Partners, Inc.") (NASDAQ:SGRY) concerning potential violations of the federal securities laws.
Surgery Partners issued a press release on November 10, 2025, announcing its financial results for the third quarter of 2025 and held an earnings call to discuss the same. The Company lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, and its adjusted EBITDA guidance to a range of $535 million to $540 million. Surgery Partners’ management attributed the guidance revision to timing delays in capital deployment, lost earnings from ambulatory surgical center divestitures, and a cautious stance on commercial payer mix and volume in the fourth quarter.
Following this news, Surgery Partners’ stock price fell over 25% on November 10, 2025.
If you suffered a loss on your Surgery Partners, Inc. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171
SOURCE: Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
COMTEX_471140441/2457/2025-12-15T19:45:10